Literature DB >> 32154773

The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.

Alex Zwanenburg1, Martin Vallières1, Mahmoud A Abdalah1, Hugo J W L Aerts1, Vincent Andrearczyk1, Aditya Apte1, Saeed Ashrafinia1, Spyridon Bakas1, Roelof J Beukinga1, Ronald Boellaard1, Marta Bogowicz1, Luca Boldrini1, Irène Buvat1, Gary J R Cook1, Christos Davatzikos1, Adrien Depeursinge1, Marie-Charlotte Desseroit1, Nicola Dinapoli1, Cuong Viet Dinh1, Sebastian Echegaray1, Issam El Naqa1, Andriy Y Fedorov1, Roberto Gatta1, Robert J Gillies1, Vicky Goh1, Michael Götz1, Matthias Guckenberger1, Sung Min Ha1, Mathieu Hatt1, Fabian Isensee1, Philippe Lambin1, Stefan Leger1, Ralph T H Leijenaar1, Jacopo Lenkowicz1, Fiona Lippert1, Are Losnegård1, Klaus H Maier-Hein1, Olivier Morin1, Henning Müller1, Sandy Napel1, Christophe Nioche1, Fanny Orlhac1, Sarthak Pati1, Elisabeth A G Pfaehler1, Arman Rahmim1, Arvind U K Rao1, Jonas Scherer1, Muhammad Musib Siddique1, Nanna M Sijtsema1, Jairo Socarras Fernandez1, Emiliano Spezi1, Roel J H M Steenbakkers1, Stephanie Tanadini-Lang1, Daniela Thorwarth1, Esther G C Troost1, Taman Upadhaya1, Vincenzo Valentini1, Lisanne V van Dijk1, Joost van Griethuysen1, Floris H P van Velden1, Philip Whybra1, Christian Richter1, Steffen Löck1.   

Abstract

Background Radiomic features may quantify characteristics present in medical imaging. However, the lack of standardized definitions and validated reference values have hampered clinical use. Purpose To standardize a set of 174 radiomic features. Materials and Methods Radiomic features were assessed in three phases. In phase I, 487 features were derived from the basic set of 174 features. Twenty-five research teams with unique radiomics software implementations computed feature values directly from a digital phantom, without any additional image processing. In phase II, 15 teams computed values for 1347 derived features using a CT image of a patient with lung cancer and predefined image processing configurations. In both phases, consensus among the teams on the validity of tentative reference values was measured through the frequency of the modal value and classified as follows: less than three matches, weak; three to five matches, moderate; six to nine matches, strong; 10 or more matches, very strong. In the final phase (phase III), a public data set of multimodality images (CT, fluorine 18 fluorodeoxyglucose PET, and T1-weighted MRI) from 51 patients with soft-tissue sarcoma was used to prospectively assess reproducibility of standardized features. Results Consensus on reference values was initially weak for 232 of 302 features (76.8%) at phase I and 703 of 1075 features (65.4%) at phase II. At the final iteration, weak consensus remained for only two of 487 features (0.4%) at phase I and 19 of 1347 features (1.4%) at phase II. Strong or better consensus was achieved for 463 of 487 features (95.1%) at phase I and 1220 of 1347 features (90.6%) at phase II. Overall, 169 of 174 features were standardized in the first two phases. In the final validation phase (phase III), most of the 169 standardized features could be excellently reproduced (166 with CT; 164 with PET; and 164 with MRI). Conclusion A set of 169 radiomics features was standardized, which enabled verification and calibration of different radiomics software. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Kuhl and Truhn in this issue.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32154773      PMCID: PMC7193906          DOI: 10.1148/radiol.2020191145

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  32 in total

1.  Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis.

Authors:  Alex Zwanenburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-25       Impact factor: 9.236

Review 2.  Characterization of PET/CT images using texture analysis: the past, the present… any future?

Authors:  Mathieu Hatt; Florent Tixier; Larry Pierce; Paul E Kinahan; Catherine Cheze Le Rest; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-06       Impact factor: 9.236

3.  Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings.

Authors:  Mathias Meyer; James Ronald; Federica Vernuccio; Rendon C Nelson; Juan Carlos Ramirez-Giraldo; Justin Solomon; Bhavik N Patel; Ehsan Samei; Daniele Marin
Journal:  Radiology       Date:  2019-10-01       Impact factor: 11.105

Review 4.  A Deep Look Into the Future of Quantitative Imaging in Oncology: A Statement of Working Principles and Proposal for Change.

Authors:  Olivier Morin; Martin Vallières; Arthur Jochems; Henry C Woodruff; Gilmer Valdes; Steve E Braunstein; Joachim E Wildberger; Javier E Villanueva-Meyer; Vasant Kearney; Sue S Yom; Timothy D Solberg; Philippe Lambin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-28       Impact factor: 7.038

5.  Deep Learning-based Image Conversion of CT Reconstruction Kernels Improves Radiomics Reproducibility for Pulmonary Nodules or Masses.

Authors:  Jooae Choe; Sang Min Lee; Kyung-Hyun Do; Gaeun Lee; June-Goo Lee; Sang Min Lee; Joon Beom Seo
Journal:  Radiology       Date:  2019-06-18       Impact factor: 11.105

6.  Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis.

Authors:  Fanny Orlhac; Michaël Soussan; Jacques-Antoine Maisonobe; Camilo A Garcia; Bruno Vanderlinden; Irène Buvat
Journal:  J Nucl Med       Date:  2014-02-18       Impact factor: 10.057

Review 7.  Predictive biomarkers: a paradigm shift towards personalized cancer medicine.

Authors:  Nicholas B La Thangue; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2011-08-23       Impact factor: 66.675

8.  A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer.

Authors:  Haonan Lu; Mubarik Arshad; Andrew Thornton; Giacomo Avesani; Paula Cunnea; Ed Curry; Fahdi Kanavati; Jack Liang; Katherine Nixon; Sophie T Williams; Mona Ali Hassan; David D L Bowtell; Hani Gabra; Christina Fotopoulou; Andrea Rockall; Eric O Aboagye
Journal:  Nat Commun       Date:  2019-02-15       Impact factor: 14.919

9.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

10.  Test-Retest Data for Radiomics Feature Stability Analysis: Generalizable or Study-Specific?

Authors:  Janna E van Timmeren; Ralph T H Leijenaar; Wouter van Elmpt; Jiazhou Wang; Zhen Zhang; André Dekker; Philippe Lambin
Journal:  Tomography       Date:  2016-12
View more
  522 in total

1.  Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach.

Authors:  Yi Zhou; Xue-Lei Ma; Ting Zhang; Jian Wang; Tao Zhang; Rong Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-05       Impact factor: 9.236

2.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

3.  iGLASS: imaging integration into the Glioma Longitudinal Analysis Consortium.

Authors:  Spyridon Bakas; David Ryan Ormond; Kristin D Alfaro-Munoz; Marion Smits; Lee Alex Donald Cooper; Roel Verhaak; Laila M Poisson
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

4.  Technical Note: MRQy - An open-source tool for quality control of MR imaging data.

Authors:  Amir Reza Sadri; Andrew Janowczyk; Ren Zhou; Ruchika Verma; Niha Beig; Jacob Antunes; Anant Madabhushi; Pallavi Tiwari; Satish E Viswanath
Journal:  Med Phys       Date:  2020-11-27       Impact factor: 4.071

5.  Radiomic ADC Metrics as a Tool to Better Understand Tumor Biology.

Authors:  Caroline Reinhold; Stephanie Nougaret
Journal:  Radiol Imaging Cancer       Date:  2020-05-22

Review 6.  Deep learning in histopathology: the path to the clinic.

Authors:  Jeroen van der Laak; Geert Litjens; Francesco Ciompi
Journal:  Nat Med       Date:  2021-05-14       Impact factor: 53.440

7.  Analyzing magnetic resonance imaging data from glioma patients using deep learning.

Authors:  Bjoern Menze; Fabian Isensee; Roland Wiest; Bene Wiestler; Klaus Maier-Hein; Mauricio Reyes; Spyridon Bakas
Journal:  Comput Med Imaging Graph       Date:  2020-12-02       Impact factor: 4.790

8.  Automatic Machine Learning to Differentiate Pediatric Posterior Fossa Tumors on Routine MR Imaging.

Authors:  H Zhou; R Hu; O Tang; C Hu; L Tang; K Chang; Q Shen; J Wu; B Zou; B Xiao; J Boxerman; W Chen; R Y Huang; L Yang; H X Bai; C Zhu
Journal:  AJNR Am J Neuroradiol       Date:  2020-07       Impact factor: 3.825

9.  Virtual clinical trial for quantifying the effects of beam collimation and pitch on image quality in computed tomography.

Authors:  Ehsan Abadi; William P Segars; Brian Harrawood; Shobhit Sharma; Anuj Kapadia; Ehsan Samei
Journal:  J Med Imaging (Bellingham)       Date:  2020-06-01

10.  Overall survival prediction in glioblastoma patients using structural magnetic resonance imaging (MRI): advanced radiomic features may compensate for lack of advanced MRI modalities.

Authors:  Spyridon Bakas; Gaurav Shukla; Hamed Akbari; Guray Erus; Aristeidis Sotiras; Saima Rathore; Chiharu Sako; Sung Min Ha; Martin Rozycki; Russell T Shinohara; Michel Bilello; Christos Davatzikos
Journal:  J Med Imaging (Bellingham)       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.